JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CALA
4326
DELISTED
Calithera Biosciences, Inc
CALA
| $117K | ﹤0.01% |
1,106
+332
| +43% | +$39.4K |
2017 Q4
10 quarters
|
|
|
CLCT
4327
DELISTED
Collectors Universe
CLCT
| $117K | ﹤0.01% |
3,408
-15,147
| -82% | -$344K |
2017 Q3
11 quarters
|
|
4328
WisdomTree US AI Enhanced Value Fund
AIVL
$413M
| $116K | ﹤0.01% |
1,580
| – | – |
2014 Q4
22 quarters
|
|
4329
Clearfield
CLFD
$451M
| $116K | ﹤0.01% |
8,382
-9,039
| -52% | -$117K |
2017 Q4
10 quarters
|
|
4330
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$672M
| $115K | ﹤0.01% |
2,375
+411
| +21% | +$19.6K |
2016 Q4
14 quarters
|
|
4331
Cytosorbents Corp
CTSO
$12.4M
| $115K | ﹤0.01% |
580
+91
| +19% | +$16.7K |
2018 Q2
8 quarters
|
|
4332
First Capital
FCAP
$213M
| $115K | ﹤0.01% |
1,648
-1,803
| -52% | -$106K |
2019 Q1
5 quarters
|
|
|
KZR
4333
DELISTED
Kezar Life Sciences
KZR
| $115K | ﹤0.01% |
2,233
+1,232
| +123% | +$62.2K |
2018 Q3
7 quarters
|
|
4334
Veritone
VERI
$75M
| $115K | ﹤0.01% |
+7,722
| New | +$64.9K |
2020 Q2
0 quarters
|
|
|
TLRD
4335
DELISTED
Tailored Brands, Inc.
TLRD
| $115K | ﹤0.01% |
122,784
+82,825
| +207% | +$110K |
2016 Q1
17 quarters
|
|
|
AFMD
4336
DELISTED
Affimed
AFMD
| $114K | ﹤0.01% |
2,477
+127
| +5% | +$3.53K |
2019 Q2
4 quarters
|
|
4337
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.42B
| $114K | ﹤0.01% |
4,778
-30,046
| -86% | -$644K |
2017 Q4
10 quarters
|
|
4338
Hackett Group
HCKT
$268M
| $114K | ﹤0.01% |
8,418
-161,037
| -95% | -$2.22M |
2015 Q4
18 quarters
|
|
|
MBCN
4339
DELISTED
Middlefield Banc Corp
MBCN
| $114K | ﹤0.01% |
+5,483
| New | +$102K |
2020 Q2
0 quarters
|
|
4340
Motorcar Parts of America
MPAA
$201M
| $114K | ﹤0.01% |
6,425
+186
| +3% | +$2.63K |
2017 Q4
10 quarters
|
|
4341
Innovator US Equity Power Buffer ETF March
PMAR
$749M
| $114K | ﹤0.01% |
4,255
+1,272
| +43% | +$32.9K |
2020 Q1
1 quarter
|
|
4342
Construction Partners
ROAD
$5.12B
| $113K | ﹤0.01% |
6,383
+572
| +10% | +$9.75K |
2019 Q2
4 quarters
|
|
4343
Willis Lease Finance
WLFC
$914M
| $113K | ﹤0.01% |
14,007
-22,212
| -61% | -$158K |
2017 Q4
10 quarters
|
|
|
NBSE
4344
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $113K | ﹤0.01% |
+645
| New | +$108K |
2020 Q2
0 quarters
|
|
4345
Mistras Group
MG
$659M
| $112K | ﹤0.01% |
28,537
-13,315
| -32% | -$55.1K |
2017 Q4
10 quarters
|
|
4346
Miller Industries
MLR
$616M
| $112K | ﹤0.01% |
3,775
-13,588
| -78% | -$387K |
2017 Q4
10 quarters
|
|
4347
ProShares Short S&P500
SH
$972M
| $112K | ﹤0.01% |
1,251
+694
| +125% | +$66.7K |
2018 Q3
7 quarters
|
|
4348
Stoke Therapeutics
STOK
$1.64B
| $112K | ﹤0.01% |
4,691
-814
| -15% | -$19.3K |
2019 Q3
3 quarters
|
|
4349
Tilly's
TLYS
$140M
| $112K | ﹤0.01% |
19,890
-597,524
| -97% | -$3.08M |
2015 Q1
21 quarters
|
|
4350
Invesco S&P MidCap Low Volatility ETF
XMLV
$695M
| $112K | ﹤0.01% |
2,696
| – | – |
2018 Q1
9 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.